Dr. Cesarman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
# 69
New York, NY 10065Phone+1 646-253-2808Fax+1 212-746-3856
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1988 - 1992
- Autonomous Metropolitan University XochimilcoClass of 1981
Certifications & Licensure
- NY State Medical License 1991 - 2025
- American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2001
Publications & Presentations
PubMed
- 855 citationsPrimary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.Roland G. Nador, Ethel Cesarman, Amy Chadburn, DB Dawson, MQ Ansari
Blood. 1996-07-15 - 46 citationsRapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study.Susan E. Krown, Debasmita Roy, Jeannette Y. Lee, Bruce J. Dezube, Erin Reid
Journal of Acquired Immune Deficiency Syndromes. 2012-04-15 - 52 citationsInhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.Lisa Giulino-Roth, Herman van Besien, Tanner Dalton, Jennifer Totonchy, Anna Rodina
Molecular Cancer Therapeutics. 2017-06-15
Abstracts/Posters
- Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's LymphomaEthel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085Ethel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Combined EZH2 and BCL2 Inhibitors As Precision Therapy for Genetically Defined DLBCL SubtypesEthel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- Weill Cornell Medicine Awarded NCI Grant for EBV-Related Lymphoma ResearchFebruary 23rd, 2023
- Portable Diagnostic Device Helps African Physicians Diagnose CancerAugust 24th, 2022
- TINY Cancer Detection Device Proves Effective in Uganda TestingSeptember 12th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: